Our study not only highlights the potential benefits of GLP-1 RAs in enhancing the health-related quality of life but also provides valuable insights into the cost-effectiveness of oral semaglutide in poorly controlled Chinese patients with T2DM on basal insulin. Here, GLP1R is linked to type 2 diabetes mellitus.